EHC is proud to announce the launch of its collaborative educational project together with the ERN-EuroBloodNet “Topic on Focus: von Willebrand Disease (VWD)” for patients, patient organisations, and healthcare professionals.

To register for the whole programme or selected webinars, please visit the ERN EuroBloodNet website. 

This project is coordinated by the ERN and the EHC represented by the EHC VWD Committee and VWD patient representatives. This educational programme is created in partnership with EURORDIS-Rare Diseases Europe and supported by members of the scientific committee: Prof Sophie Susen (CHU de Lille, France), Prof Jeroen Eikenboom (Leiden University Medical Center, the Netherlands), and Prof Flora Peyvandi (Foundation IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, Italy).

VWD is the most common bleeding disorder affecting up to 1% of the general population, however, VWD is often neglected and overshadowed by haemophilia. This programme aims to distinguish VWD from haemophilia and focuses on the particularities of this bleeding disorder. The programme also aims to discuss very topical areas related to VWD among patients and healthcare professionals to give visibility to the challenges of those living with this rare disease, including quality of life, access to treatments and care, medical services available in Europe, diagnosis and treatments options, and the overall patient journey through life. A further objective of this programme is to disseminate up-to-date knowledge among interested haematologists, gynaecologists, internists, paediatricians, nurses or other healthcare providers and patient organisations in the field of VWD. Ultimately, this approach aims to support better patient care.

This programme is accredited by the European Board of Accreditation in Hematology. Participants will receive 1 Continuing Medical Education points when they take part in one online webinar.

The launch of the program is timed to correspond with the European VWD Awareness Day, the 1st of February.

PROGRAMME

PROGRAMME

Please contact us for any questions at [email protected].